Medscape: Analysis boosts Fluvoxamine for COVID, but what's the evidence?
UC expert says research may be useful, but more trials are needed
A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 treatment arsenal. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
"This research might be valuable, but the jury remains out until several other adequately powered and designed trials are completed," said Fichtenbaum, who's familiar with the findings. "I'm not sure how useful this is given we have several antiviral agents available. Why would we choose this over Paxlovid, remdesivir, or molnupiravir?"
According to Fichtenbaum, researchers began focusing on fluvoxamine after case reports about patients improving while on the medication. This led to further interest, he said, boosted by the drug's known ability to dampen the immune system.
Lead photo/Science News
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
WVXU: Could this low-cost fix improve habitat in streams?
May 11, 2022
WVXU highlights a demonstration project led by the University of Cincinnati to find low-cost ways to improve the health of urban streams. The project aims to increase biodiversity by providing more wildlife habitat.
Parade: Fidget toys can be coping tools for depression and...
May 11, 2022
The University of Cincinnati's Shana Feibel was featured in a Parade article about the benefits of fidget toys to cope with anxiety and depression.
Scientific American: Is it COVID-19 or is it allergies?
May 11, 2022
Ahmad Sedaghat, MD, PhD, associate professor and director of the Division of Rhinology, Allergy and Anterior Skull Base Surgery in the UC College of Medicine was interviewed for a story published by Scientific American on the differences between allergies and COVID-19.